Crossmark Global Holdings, Inc. Haemonetics Corp Transaction History

Crossmark Global Holdings, Inc.

$5.5 Billion
Q1 2025

A detailed history of Crossmark Global Holdings, Inc. transactions in Haemonetics Corp stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 5,854 shares of HAE stock, worth $419,439. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,854

Previous 5,884 0.51%

Holding current value

$419,439

Previous $459,000 18.95%

% of portfolio

0.01%

Previous 0.01%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 29, 2025	SELL	$59.34 - $80.05 $1,780 - $2,401	-30 Reduced 0.51%	5,854 $372,000
Q4 2024 Jan 16, 2025	SELL	$71.16 - $93.38 $44,830 - $58,829	-630 Reduced 9.67%	5,884 $459,000
Q3 2024 Nov 04, 2024	SELL	$72.45 - $91.58 $252,415 - $319,064	-3,484 Reduced 34.85%	6,514 $524,000
Q2 2024 Jul 29, 2024	BUY	$81.24 - $97.37 $192,538 - $230,766	2,370 Added 31.07%	9,998 $827,000
Q1 2024 May 13, 2024	BUY	$71.24 - $85.35 $285,102 - $341,570	4,002 Added 110.37%	7,628 $651,000
Q4 2023 Feb 13, 2024	SELL	$80.59 - $92.61 $31,671 - $36,395	-393 Reduced 9.78%	3,626 $310,000
Q3 2023 Nov 08, 2023	SELL	$82.56 - $93.49 $3,384 - $3,833	-41 Reduced 1.01%	4,019 $372,000
Q2 2023 Jul 31, 2023	SELL	$80.84 - $89.45 $22,311 - $24,688	-276 Reduced 6.37%	4,060 $377,000
Q1 2023 May 12, 2023	BUY	$72.75 - $90.6 $10,767 - $13,408	148 Added 3.53%	4,336 $358,000
Q4 2022 Jan 19, 2023	BUY	$73.85 - $86.14 $6,129 - $7,149	83 Added 2.02%	4,188 $330,000
Q3 2022 Nov 01, 2022	SELL	$63.3 - $78.66 $19,306 - $23,991	-305 Reduced 6.92%	4,105 $304,000
Q2 2022 Jul 29, 2022	SELL	$49.27 - $66.08 $492 - $660	-10 Reduced 0.23%	4,410 $287,000
Q1 2022 May 11, 2022	BUY	$43.77 - $63.22 $437 - $632	10 Added 0.23%	4,420 $279,000
Q4 2021 Jan 10, 2022	BUY	$49.55 - $74.59 $25,270 - $38,040	510 Added 13.08%	4,410 $234,000
Q3 2021 Oct 21, 2021	SELL	$57.6 - $70.59 $69,120 - $84,708	-1,200 Reduced 23.53%	3,900 $275,000
Q3 2021 Oct 13, 2021	BUY	$57.6 - $70.59 $67,968 - $83,296	1,180 Added 30.1%	5,100 $205,000
Q2 2021 Jul 21, 2021	SELL	$51.81 - $118.56 $23,314 - $53,352	-450 Reduced 10.3%	3,920 $261,000
Q1 2021 Apr 15, 2021	SELL	$111.01 - $139.48 $2,220 - $2,789	-20 Reduced 0.46%	4,370 $485,000
Q4 2020 Jan 14, 2021	SELL	$88.75 - $119.95 $11,537 - $15,593	-130 Reduced 2.88%	4,390 $521,000
Q3 2020 Oct 08, 2020	SELL	$75.65 - $93.58 $9,834 - $12,165	-130 Reduced 2.8%	4,520 $394,000
Q2 2020 Aug 14, 2020	BUY	$84.96 - $118.91 $39,931 - $55,887	470 Added 11.24%	4,650 $416,000
Q1 2020 Apr 28, 2020	SELL	$74.34 - $121.82 $5,203 - $8,527	-70 Reduced 1.65%	4,180 $416,000
Q4 2019 Feb 06, 2020	SELL	$114.37 - $129.46 $89,208 - $100,978	-780 Reduced 15.51%	4,250 $488,000
Q3 2019 Oct 09, 2019	SELL	$117.16 - $138.52 $29,290 - $34,630	-250 Reduced 4.73%	5,030 $634,000
Q2 2019 Jul 09, 2019	SELL	$81.74 - $120.34 $29,344 - $43,202	-359 Reduced 6.37%	5,280 $635,000
Q1 2019 May 02, 2019	BUY	$83.25 - $102.12 $7,492 - $9,190	90 Added 1.62%	5,639 $493,000
Q4 2018 Jan 31, 2019	BUY	$90.66 - $116.63 $84,313 - $108,465	930 Added 20.13%	5,549 $555,000
Q3 2018 Nov 08, 2018	SELL	$89.96 - $114.58 $5,397 - $6,874	-60 Reduced 1.28%	4,619 $529,000
Q2 2018 Jul 31, 2018	SELL	$71.53 - $95.75 $246,778 - $330,337	-3,450 Reduced 42.44%	4,679 $420,000
Q1 2018 Apr 16, 2018	SELL	$60.72 - $74.41 $118,343 - $145,025	-1,949 Reduced 19.34%	8,129 $595,000
Q4 2017 Feb 05, 2018	BUY	$44.96 - $58.99 $10,295 - $13,508	229 Added 2.33%	10,078 $585,000
Q3 2016 Oct 25, 2017	BUY	N/A	9,849	9,849 $442,000

Others Institutions Holding HAE

# of Institutions

351

Shares Held

53.3M

Call Options Held

417K

Put Options Held

314K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.68B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.

Account

Crossmark Global Holdings, Inc. Haemonetics Corp Transaction History